why choose us

First received: November 07, 2023

Clinical Trial: Using Mirabegron to Increase BP in Patients With POTS

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Postural Orthostatic Tachycardia Syndrome

Study Type: INTERVENTIONAL


Official Title: Using Mirabegron to Increase Blood Pressure in Patients With Postural Orthostatic Tachycardia Syndrome

Brief Summary: This is a pilot dose-finding study to test the hypothesis that mirabegron increases systolic blood pressure (BP), prevents syncope/presyncope, and improves the quality of life (QOL), functional capacity, chest pain, and overactive bladder (OAB) symptoms in patients with postural orthostatic tachycardia syndrome (POTS) who have a documented history of hypotension inadequately responsive to conventional treatments.The American Heart Association funds this study.

Read more